Short-term effectiveness of intelligent navigated laser photocoagulation versus subthreshold micropulse laser in patients with chronic central serous chorioretinopathy  

作　　者：Fen Zhou Cheng-Hu Wang Chen-Chen Zhou Sha Liu Jin Yao Qin Jiang 

机构地区：[1]Nanjing Medical University Affiliated Eye Hospital,Nanjing 290091,Jiangsu Province,China

出　　处：《International Journal of Ophthalmology(English edition)》2024年第11期2045-2051,共7页国际眼科杂志（英文版）

摘　　要：AIM:To compare the short-term effectiveness of intelligent navigated laser photocoagulation and 577-nm subthreshold micropulse laser(SML)treatment in patients with chronic central serous chorioretinopathy(cCSC).METHODS:This observational retrospective cohort study included 60 consecutive patients who underwent intelligent navigated laser photocoagulation(n=30)or 577-nm SML treatment(n=30)for cCSC between Jan.2021 and Oct.2022.During 3mo follow-up,all patients underwent assessments of best correct visual acuity(BCVA)and optical coherence tomography(OCT).RESULTS:The operation of laser treatment was successful in all cases.At 1mo,BCVA improved significantly more in the intelligent navigated laser photocoagulation group compared to the SML group(P<0.05).The change was not significantly different at 3mo(P>0.05).Central macular thickness(CMT)in the intelligent navigated laser photocoagulation group was lower than in the SML group at 1mo(P<0.05).The subfoveal choroidal thickness(SFCT)in two groups were all significantly improved at 3mo(all P<0.05).The change between two groups was not significantly different at 1mo or at 3mo(P>0.05).CONCLUSION:Intelligent navigated laser photocoagulation is superior to SML for treating cCSC,leading to better improvements in vision and CMT for short term.

关 键 词：intelligent navigated laser photocoagulation subthreshold micropulse laser central serous chorioretinopathy optical coherence tomography 

分 类 号：R774.1[医药卫生—眼科]